Nu Skin Enterprises Management
Management criteria checks 2/4
Nu Skin Enterprises' CEO is Ryan Napierski, appointed in Mar 2017, has a tenure of 7.83 years. total yearly compensation is $5.84M, comprised of 17% salary and 83% bonuses, including company stock and options. directly owns 0.21% of the company’s shares, worth $730.47K. The average tenure of the management team and the board of directors is 12.3 years and 12.3 years respectively.
Key information
Ryan Napierski
Chief executive officer
US$5.8m
Total compensation
| CEO salary percentage | 17.0% |
| CEO tenure | 7.8yrs |
| CEO ownership | 0.2% |
| Management average tenure | 12.3yrs |
| Board average tenure | 12.3yrs |
Recent management updates
Recent updates
Nu Skin: New Cash From Mavely's Sale Could Accelerate Inorganic Growth
Jan 09Nu Skin Enterprises (NYSE:NUS) Will Be Looking To Turn Around Its Returns
Dec 21
Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?
Nov 12Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation
Nov 12The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%
Oct 04Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business
Aug 31Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price
Aug 13Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year
May 30Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?
May 13Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal
Mar 28Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty
Mar 04We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings
Feb 22Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06
Feb 19Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically
Feb 18Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks
Jan 18Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet
Dec 14Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39
Nov 17Nu Skin: Is It Just A Growth Problem?
Oct 17Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company
Oct 09When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?
Sep 27Nu Skin: Attractive Valuation Trumps Near-Term Risks
Sep 12Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt
Sep 08Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39
Aug 05Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value
Jul 31Nu Skin: A High-Risk/High-Reward Turnaround Play Worth The Risks
Jun 26Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?
Jun 23We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt
May 22Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39
May 07Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital
Apr 26Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching
Mar 18CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$103m |
| Jun 30 2024 | n/a | n/a | -US$148m |
| Mar 31 2024 | n/a | n/a | -US$3m |
| Dec 31 2023 | US$6m | US$992k | US$9m |
| Sep 30 2023 | n/a | n/a | US$59m |
| Jun 30 2023 | n/a | n/a | US$70m |
| Mar 31 2023 | n/a | n/a | US$77m |
| Dec 31 2022 | US$5m | US$942k | US$105m |
| Sep 30 2022 | n/a | n/a | US$38m |
| Jun 30 2022 | n/a | n/a | US$113m |
| Mar 31 2022 | n/a | n/a | US$139m |
| Dec 31 2021 | US$5m | US$801k | US$147m |
| Sep 30 2021 | n/a | n/a | US$230m |
| Jun 30 2021 | n/a | n/a | US$237m |
| Mar 31 2021 | n/a | n/a | US$219m |
| Dec 31 2020 | US$4m | US$721k | US$191m |
| Sep 30 2020 | n/a | n/a | US$158m |
| Jun 30 2020 | n/a | n/a | US$146m |
| Mar 31 2020 | n/a | n/a | US$150m |
| Dec 31 2019 | US$2m | US$688k | US$174m |
| Sep 30 2019 | n/a | n/a | US$116m |
| Jun 30 2019 | n/a | n/a | US$125m |
| Mar 31 2019 | n/a | n/a | US$129m |
| Dec 31 2018 | US$3m | US$621k | US$122m |
Compensation vs Market: Ryan's total compensation ($USD5.84M) is above average for companies of similar size in the US market ($USD2.22M).
Compensation vs Earnings: Ryan's compensation has increased whilst the company is unprofitable.
CEO
Ryan Napierski (50 yo)
7.8yrs
Tenure
US$5,838,579
Compensation
Mr. Ryan S. Napierski has been Chief Executive Officer of Nu Skin Enterprises Inc. since September 1, 2021. Mr. Napierski has been the President of Nu Skin Enterprises Inc. since March 7, 2017 and has been...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman of the Board | 29yrs | US$856.61k | 0.24% $ 835.7k | |
| President | 7.8yrs | US$5.84m | 0.21% $ 730.5k | |
| Executive VP | 5.4yrs | US$1.86m | 0.14% $ 504.8k | |
| Executive VP & Chief Scientific Officer | 18.9yrs | US$1.12m | 0.19% $ 648.0k | |
| Executive VP & General Counsel | 3.4yrs | US$2.28m | 0.30% $ 1.0m | |
| Executive VP & Chief Product Officer | 7yrs | US$1.41m | 0.19% $ 674.0k | |
| Founder | 41yrs | US$621.69k | no data | |
| Founder | 29yrs | US$1.06m | no data | |
| Senior VP & CTO | 4yrs | no data | no data | |
| Chief Information Officer | 18.9yrs | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Chief Marketing Officer | 16.7yrs | no data | no data |
12.3yrs
Average Tenure
66yo
Average Age
Experienced Management: NUS's management team is seasoned and experienced (12.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman of the Board | 29yrs | US$856.61k | 0.24% $ 835.7k | |
| President | 3.6yrs | US$5.84m | 0.21% $ 730.5k | |
| Independent Director | 9.6yrs | US$273.20k | 0.033% $ 115.3k | |
| Lead Independent Director | 27.8yrs | US$280.20k | 0.21% $ 741.0k | |
| Member of Anti-Aging Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 16.6yrs | US$257.08k | 0.15% $ 505.9k | |
| Member of the Anti-Aging Scientific Advisory Board | 15yrs | no data | no data | |
| Member of Anti-Aging Scientific Advisory Board | no data | no data | no data | |
| Member of Anti-aging Scientific Advisory Board | 15.3yrs | no data | no data | |
| Director | 8.5yrs | US$249.20k | 0.044% $ 153.3k | |
| Independent Director | 5.6yrs | US$268.20k | 0.044% $ 151.6k | |
| Independent Director | 3.6yrs | US$264.33k | 0.039% $ 134.8k |
12.3yrs
Average Tenure
67.5yo
Average Age
Experienced Board: NUS's board of directors are seasoned and experienced ( 12.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/20 06:19 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nu Skin Enterprises, Inc. is covered by 15 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anand Vankawala | Avondale Partners |
| Olivia Tong Cheang | BofA Global Research |
| April Scee | BTIG |